- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Altria Client Services LLC v. R.J. Reynolds Vapor Company
Case Type | 830 Patent |
Tags | 830 Patent, 830 Patent |
Deadline | MOTION of Appellant R.J. Reynolds Vapor Company to extend the time to 04/28/2025 to file brief., The opening brief is due 04/28/2025. |
Plaintiff - Appellee | ALTRIA CLIENT SERVICES LLC |
Defendant - Appellant | R.J. REYNOLDS VAPOR COMPANY |

Altria Client Services LLC v. R.J. Reynolds Vapor Company
Case Type | 830 Patent |
Tags | 830 Patent, 830 Patent |
Deadline | The following conflict dates requested by Mark Andrew Perry for Altria Client Services LLC (see Doc. No. [52]) are not accepted at this time: 03/06/2025, 03/07/2025, 05/05/2025, 05/06/2025. |
Plaintiff - Appellee | ALTRIA CLIENT SERVICES LLC |
Plaintiff - Appellee | U.S. SMOKELESS TOBACCO COMPANY LLC |
Defendant - Appellant | R.J. REYNOLDS VAPOR COMPANY |
... |

- Search within this case
Analyze Judge
Analyze Party
Analyze Firm
AI Visualize, Inc. v. Nuance Communications, Inc.
Case Type | 830 Patent |
Tags | 830 Patent, 830 Patent |
Plaintiff - Appellant | AI VISUALIZE, INC. |
Defendant - Appellee | NUANCE COMMUNICATIONS, INC. |
Defendant - Appellee | MACH7 TECHNOLOGIES, INC. |
... |

- Search within this case
Analyze Judge
Analyze Party
Analyze Firm
Regeneron Pharmaceuticals Inc. v. Novartis Pharma AG et al
Deadline | Non-expert depositions shall be completed by June 13, 2025., Fact Discovery due by 6/13/2025. |
Deadline | Discovery due by 10/24/2025., Expert Discovery due by 10/24/2025., Responses due by 12/16/2025 Deposition due by 10/24/2025. |
Plaintiff | Regeneron Pharmaceuticals Inc. |
Defendant | Novartis Pharma AG |
Regeneron Pharmaceuticals, Inc v. Novartis Pharma AG
Case Type | 3410 Anti-Trust |
Tags | 3410 Anti-Trust, 3410 Anti-Trust |
Plaintiff - Appellant | Regeneron Pharmaceuticals, Inc. |
Defendant - Appellee | Novartis Pharma AG |
Defendant - Appellee | Novartis Technology LLC |
... |

- Search within this case
Analyze Party
Analyze Firm
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
|

Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
|

In Re: Aflibercept Patent Litigation
|
